Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Ayala Pharmaceuticals Inc News

    0,572 $ +0,35% +0,002 $
    In : 0,5368 € | 19.04.24 19:47:15 Nasdaq OTC Other aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A3DMBH
    ISIN: US0076244062
    US-Symbol: ADXS
    Typ: Aktie

    Ayala Pharmaceuticals Inc News

    23.12.21 - PR Newswire
    OTC Markets Group Welcomes Advaxis, Inc. to OTCQX
    OTC Markets Group Welcomes Advaxis, Inc. to OTCQX PR Newswire
    26.08.21 - PR Newswire
    Thinking about buying stock in Zomedica, Advaxis, Kaixin Auto, SelectQuote, or Coty?
    Thinking about buying stock in Zomedica, Advaxis, Kaixin Auto, SelectQuote, or Coty? PR Newswire
    16.07.21 - PR Newswire
    SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Advaxis, Inc. - ADXS
    SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Advaxis, Inc. - ADXS PR Newswire
    14.07.21 - PR Newswire
    INVESTIGATION ALERT: Halper Sadeh LLP Investigates STFC, HBMD, ICBK, ADXS, FOE; Shareholders are Encouraged to Contact the Firm
    INVESTIGATION ALERT: Halper Sadeh LLP Investigates STFC, HBMD, ICBK, ADXS, FOE; Shareholders are Encouraged to Contact the Firm PR Newswire
    13.07.21 - PR Newswire
    SHAREHOLDER ALERT: WeissLaw LLP Reminds UFS, ADXS, QADA; QADB, and SNR Shareholders About Its Ongoing Investigations
    SHAREHOLDER ALERT: WeissLaw LLP Reminds UFS, ADXS, QADA; QADB, and SNR Shareholders About Its Ongoing Investigations PR Newswire
    07.07.21 - PR Newswire
    INVESTIGATION ALERT: Halper Sadeh LLP Investigates USCR, QTS, MCF, ADXS; Shareholders are Encouraged to Contact the Firm
    INVESTIGATION ALERT: Halper Sadeh LLP Investigates USCR, QTS, MCF, ADXS; Shareholders are Encouraged to Contact the Firm PR Newswire
    06.07.21 - PR Newswire
    SHAREHOLDER ALERT: WeissLaw LLP Investigates Advaxis, Inc.
    SHAREHOLDER ALERT: WeissLaw LLP Investigates Advaxis, Inc. PR Newswire
    20.05.21 - PR Newswire
    Thinking about buying stock in Advaxis, Cisco Systems, Atossa Therapeutics, Palantir Technologies, or Sundial Growers?
    Thinking about buying stock in Advaxis, Cisco Systems, Atossa Therapeutics, Palantir Technologies, or Sundial Growers? PR Newswire
    19.05.21 - PR Newswire
    Thinking about buying stock in Advaxis, Fubotv, Sundial Growers, Riot Blockchain, or Vipshop Holdings?
    Thinking about buying stock in Advaxis, Fubotv, Sundial Growers, Riot Blockchain, or Vipshop Holdings? PR Newswire
    01.04.19 - PR Newswire
    Thinking about buying stock in Aurora Cannabis Inc., Advaxis Inc., Caesars Entertainment Corp., Estre Ambiental Inc., or New Concept Energy Inc.?
    Thinking about buying stock in Aurora Cannabis Inc., Advaxis Inc., Caesars Entertainment Corp., Estre Ambiental Inc., or New Concept Energy Inc.? PR Newswire
    05.06.17 - PR Newswire
    SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Advaxis, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
    SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Advaxis, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
    01.06.17 - PR Newswire
    Synthetic Genomics Launches cGMP Suite for Pharmaceutical Quality Manufacturing of Synthetic DNA for Advaxis' Clinical Trials
    Synthetic Genomics Launches cGMP Suite for Pharmaceutical Quality Manufacturing of Synthetic DNA for Advaxis' Clinical Trials Customized suite to support Phase 1 study of ...
    27.02.17 - PR Newswire
    Advaxis and SELLAS Announce Licensing Agreement for Development of WT1 Antigen-Targeting Immunotherapy
    Advaxis and SELLAS Announce Licensing Agreement for Development of WT1 Antigen-​Targeting Immunotherapy PR Newswire
    28.10.16 - PR Newswire
    Lifshitz & Miller Law Firm Announces Investigation of Advaxis, Inc., Banc of California, Inc., Biogen Inc., Franklin Resources, Inc., Juniper Pharmaceuticals, Inc., Opus Bank, Taro Pharmaceutical
    Lifshitz & Miller Law Firm Announces Investigation of Advaxis, Inc., Banc of California, Inc., Biogen Inc., Franklin Resources, Inc., Juniper Pharmaceuticals, Inc., Opus Bank, Taro ...
    27.10.16 - PR Newswire
    SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by the Board of Advaxis, Inc. - ADXS
    SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by the Board of Advaxis, Inc. - ADXS PR Newswire
    02.08.16 - PR Newswire
    Amgen And Advaxis Enter Global Cancer Immunotherapies Collaboration
    Amgen And Advaxis Enter Global Cancer Immunotherapies Collaboration Collaboration Will Advance Highly Targeted, Patient-​Specific Treatment Approach Advaxis Will Hold a ...
    08.07.15 - PR Newswire
    Advaxis Appoints Dr. Shelonitda S. Rose as Vice President, Clinical Development
    Advaxis Appoints Dr. Shelonitda S. Rose as Vice President, Clinical Development Former Director, Oncology Clinical Research for Merck & Co. to Lead Advaxis's Growing Clinical ...
    02.07.14 - PR Newswire
    Aratana Therapeutics Files for USDA Product License of AT-014 Canine Osteosarcoma Immunotherapy
    Aratana Therapeutics Files for USDA Product License of AT-014 Canine Osteosarcoma Immunotherapy PR Newswire
    29.05.14 - PR Newswire
    Advaxis Selects inVentiv Health Clinical To Conduct Clinical Trials Of Immunotherapy Candidates
    Advaxis Selects inVentiv Health Clinical To Conduct Clinical Trials Of Immunotherapy Candidates PR Newswire
    13.05.14 - PR Newswire
    Aratana Therapeutics Reports First Quarter 2014 Results
    Aratana Therapeutics Reports First Quarter 2014 Results --Conference Call Today, May 13, 2014, 4:45 p.m. Eastern Time-- PR Newswire

    Newssuche

    Videos

    newspaper
    18.04.24
    Technical Trading: Gold mit weiterem Potenzial
    Gold Long Typ: Turbo Open End WKN: UH4MU6 Hebel: 4,67 Laufzeit: OpenEnd Einstieg: Market ... Mehr »